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Научная новизна статьи
впервые проанализированы методы выявления слабых а и в антигенов на эритроцитах в ав0 системе. 
установлено, что агглютинация эритроцитов с поликлональной сывороткой при 37ºс, антиглобулиновый 
тест при 37ºс и реакция агглютинации с комплементом способствуют выявлению слабых а и в антигенов. 
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Цель. провести анализ методов выявления слабых а и в антигенов на эритроцитах в системе ав0.
Материал и методы. проведено обследование пациентов с эндопротезированием коленного и тазо-
бедренного суставов с целью определения группоспецифической принадлежности с выявлением слабых а 
и в антигенов на эритроцитах. использованы методы абсорбции, реакция агглютинации, агглютинация в 
присутствии комплемента и антиглобулиновый тест.
Результаты. антиглобулиновый тест с использованием как поликлональной сыворотки, так и сыво-
ротки, содержащей только igG антитела, позволил выявить слабые A и b подгруппы на эритроцитах при 
37ºс. в реакции абсорбции с анти-а, анти-в поликлональными сыворотками у некоторых пациентов на 
эритроцитах выявлены а и в антигены, также проявившиеся в реакции агглютинации при 37ºс, но не об-
наруженные при инкубации при комнатной температуре. агглютинационный тест с использованием ком-
племента и сыворотки с igG антителами также способствовал проявлению слабых антигенов. присутствие 
igG антител было определено после обработки сыворотки унитиолом в антиглобулиновом тесте. наличие в 
сыворотке только igG антител, соответствующих антигенам, при участии комплемента приводило к более 
выраженным изменениям эритроцитов по сравнению с присутствием обоих классов антител – igm и igG.
появление гемолиза ассоциировалось с увеличением размеров эритроцитов и гипохромией. при-
сутствие слабых подгрупп в большинстве случаев было ассоциировано с гемолизирующими, а не агглю-
тинирующими свойствами сыворотки пациента, а также наличием комплементсвязывающих igG антител.
Заключение. применение абсорбции, агглютинация при 37ºс, антиглобулиновый тест при 37ºс с сы-
вороткой, как подвергшейся, так и не подвергшейся обработке унитиолом, а также реакция агглютинации 
с использованием комплемента способствовали определению слабых антигенов в системе ав0.
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Objective. To analyze the methods of revealing weak A and b antigens on the erythrocytes in Ab0 system.
Methods. Patients after knee and joint arthroplasty were examined on group-specific characteristics with 
revealing weak A and b antigens on the erythrocytes. methods of absorption, agglutination, agglutination with 
complement and antiglobulin test were used.
Results. Antiglobulin test with the use of polyclonal serum as well as serum containing the only igG allowed 
revealing weak A and b subgroups on erythrocytes at 37ºс. in some patients A and b antigens on erythrocytes were 
found while absorption with anti-A, anti-b polyclonal sera and also revealed in agglutination at 37ºс, but were not 
revealed while incubation at the room temperature. Agglutination test with the use of complement and igG was also 
helpful in determining the weak antigens. Presence of igG antibodies was revealed by the treatment of the serum with 
unithiol in antiglobulin test. Presence of complement and only igG antibodies corresponding to the antigens led to 
the more expressed changes of erythrocytes as compared to the presence of both types of antibodies – igm and igG.
Appearance of hemolysis was associated with the increased sizes of erythrocytes and hypochromia. Presence 
of weak subgroups was mostly associated with hemolytic rather than agglutinating abilities of the patient’s serum, as 
well as with the presence of complement binding igG antibodies.
Conclusions. Absorption, agglutination at 37ºс, antiglobulin test at 37ºc with serum both treated and non-
treated with unithiol and agglutination with use of the complement helped to define weak antigens in Ab0 system.
Keywords: antigen, blood, antiglobulin, complement, erythrocytes
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What this paper adds
For the first time, methods for the detection of weak A and b antigens on erythrocytes in Ab0 system have been 
analyzed. Agglutination of erythrocytes by polyclonal serum at 37ºс, antiglobulin test at 37ºс and agglutination with 
complement has been established to promote the detection of weak A and b antigens. Enhancement of complement 
dependent hemolysis of erythrocytes in the absence of group-specific igm and presence of only igG antibodies has 
been found out. The treatment of polyclonal serum with unithiol at 37°c helps to identify igG anti-A and anti-b 
antibodies in the antiglobulin test.
установлено усиление комплементзависимого гемолиза эритроцитов при отсутствии соответствующих груп-
поспецифических igm и наличии только igG антител. обработка унитиолом поликлональной сыворотки 
при 37°с способствует выявлению igG анти-а и анти-в антител в антиглобулиновом тесте.
Introduction
Ab0 blood groups are most important for blood 
transfusion. Weak subgroups are phenotypically rare 
and often not detected when typing blood groups, since 
these types of antigens are very poorly represented on 
the erythrocyte membrane and cannot be detected 
by conventional methods [1]. A number of authors 
discuss the advantages and disadvantages of individual 
methods in identifying weak antigens [2]. However, 
there is no consensus on the most effective way to 
detect weak Ab0 antigens. A number of methods 
are proposed that are used in the diagnosis of weak 
Ab0 blood subgroups. So, only a set of methods for 
determining weak b antigens and antibodies allows 
identifying type b antigen on erythrocytes [3].
in routine determination of group affiliation 
according to Ab0, anti-A, anti-b and anti-Ab 
antibodies are used to test erythrocytes. most 
antibodies of blood groups Ab0 are igm and are 
better detected at 4° c. The determination of blood 
groups in laboratories is carried out by direct rather 
than the reverse method, and the sequence of 
actions for determining a particular weak subgroup 
has not been defined. Weak antigens may not be 
detected, and typing results may become incorrect. 
With a large volume of surgical intervention, 
blood transfusion is one of the necessary components 
in the management of patients with knee and hip 
arthroplasty. The accuracy in determining the 
blood group and weak antigens in these patients is 
extremely important, since improper typing of the 
blood group can lead to irreversible consequences. 
in orthopedics and traumatology clinics, various 
methods of typing blood groups are not widely used 
due to the lower frequency of blood transfusions, in 
contrast to hematological clinics. However, patients 
of this profile also need the correct typing of weak 
subgroups and a description of the most effective 
methods for their determination will avoid blood 
transfusion complications. Thus, there is a need to 
analyze methods for identifying weak subgroups of 
the Ab0 system to improve the quality of diagnosis 
in typing blood groups.
Objective. To analyze the methods of revealing 
weak A and b antigens on the erythrocytes in Ab0 
system.
Methods
A detailed examination of patients with knee 
and/or hip arthroplasty requiring blood transfusion 
during arthroplasty was performed. clinical 
observations of 10 patients are presented and 
blood samples with the determination of the blood 
group of the Ab0 system using various methods 
are investigated. A study was also conducted on 
the susceptibility of erythrocytes to hemolysis and 
agglutination under the action of sera in 23 patients 
with blood group A, 10 patients with group b and 
10 patients with group 0 with determination of 
hemolizing properties of the serum. Serological 
reactions were performed using standard protocols 
[4]. The neutralization of igm anti-A and anti-b 
antibodies was carried out by a drug containing 
thiol groups – dimercaprol (unithiol) with a 
modification of the method [2]. So, one volume 
of each serum sample was mixed with an equal 
volume of unithiol and exposed at 37° c for 1 hour. 
Sera were tested for the presence of igG anti-A or 
anti-b antibodies by their ability to agglutinate in 
test tubes. Two volumes of serum after treatment 
with unithiol were mixed with one volume of 3% 
suspension of erythrocytes A or b and incubated 
at 37° c to stimulate agglutination for 1 hour. 
Samples were then examined macroscopically and 
microscopically for agglutination. Serum with the 
presence of agglutinating igG anti-A or anti-b 
antibodies was fixed. 
Results
in the routine determination of blood type 
in 10 patients, blood groups O (n=5) and A (n=5) 
were determined. in a more detailed study of 
erythrocytes samples and serums in 8 patients, the 
presence of weak antigens A (n=4) and b (n=4) 
on the erythrocyte membrane was determined. We 
present clinical observations describing the methods 
used in typing weak subgroups.
Case 1. The patient was admitted for arthroplasty 
for coxarthrosis. before surgery, his blood type was 
identified as A (Rh-) (negative). His autocontrol test 
was negative, and the erythrocytes were agglutinated 
with anti-A igG in the complement reaction and in 
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the antiglobulin test. Upon cross-reaction with the 
donor A (Rh +) (positive), his sample was recognized 
as incompatible. Additional tests were performed on 
the typing of the group according to Ab0 (tables 1-3).
His erythrocytes were also agglutinated with 
polyclonal anti-b serum at 37° c in the antiglobulin 
test and anti-b igG in the reaction with complement 
and in the antiglobulin test. The erythrocytes of 
the patient inhibited the reaction of anti-b with 
erythrocytes. Substance b was present on his 
erythrocytes, inhibiting the response of anti-b and b 
cells. His serum weakly reacted with b erythrocytes; 
however, agglutination did not appear in the 
antiglobulin test and in the presence of complement 
after treating the serum with unithiol. Thus, weak 
anti-b igm and not igG were present in the sample, 
since at 37° c after treatment with unithiol, serum 
did not agglutinate b erythrocytes, and only additional 
use of rheopolyglucinum led to agglutination. Tables 1 
to 3 show the Ab group for the direct typing method 
and the A group for the reverse one. 
Adil Salman in 1976 proposed to isolate 
weak b antigens as b3, bx, bel. According to this 
classification, bel erythrocytes do not agglutinate 
anti-b, only absorb anti-b serum.  b3 erythrocytes 
are weakly agglutinated with anti-b serum. bx 
erythrocytes are weakly agglutinated, and weak 
anti-b antibodies are detected in the blood serum 
of these individuals, and the ability of the serum to 
inhibit erythrocytes is present. Therefore, the studied 
sample belonged to the agglutination group anti-b 
and b of Abx with the presence of weak anti-b 
antibodies. it was recommended to transfuse the 
washed erythrocytes 0 with plasma Ab.
Case 2. The patient was admitted with anemia 
and instability of the endoprosthesis for arthroplasty. 
before surgery, his blood was identified as A (Rh +) 
(positive). His red blood cells agglutinated anti-A 
and anti-A, b and did not absorb anti-b.
in a cross-reaction, his serum agglutinated A 
erythrocytes at a temperature of 37° c in the presence 
and absence of complement without hemolysis, but 
hemolysis manifested itself after application of the 
LiSS solution, and weak erythrocyte hemolysis was 
also detected after treating his serum with unithiol 
in the coombs test. Thus, weak agglutinating and 
hemolysing anti-A were present in the sample.
His erythrocytes hemolysed anti-b igG in the 
antiglobulin test with weak agglutination and showed 
more pronounced agglutination and slight hemolysis 
with anti-b igG in the presence of LiSS. in the pres-
ence of polyclonal anti-b and complement, his eryth-
rocytes were weakly agglutinated, and in the presence 
of polyglucin the number of erythrocytes decreased.
Patient’s erythrocytes hemolysed in the pres-
ence of anti-A and complement, but hemolysis 
weakened in the presence of LiSS and polyglucin.
Patient's serum agglutinated b erythrocytes in a 
titer of 1: 8 with hemolysis in the presence of comple-
ment, but without hemolysis after treatment with 
unithiol. Thus, hemolytically active anti-b igm were 
present in the sample. His non-hemolytic igG anti-b 
antibodies were detected in the indirect coombs test.
After unithiol treatment, the patient's serum 
agglutinated his own red blood cells in the indirect 
antiglobulin test with slight hemolysis. His direct 
antiglobulin test (DAT) was positive. Performing 
the test at 37° c and 4° c showed hemolysis of his 
erythrocytes at 37° c; therefore, thermal autoanti-
bodies were present in the sample.
Autosorption: 
1. Plasma and erythrocytes at 37° c 15', washing 
of red blood cells, the addition of antiglobulin serum 
(AGS): + aggl., hemolysis, red supernatant.
2. Plasma and eryrhrocytes at 4° c 15', washing 
of red blood cells, the addition of AGS: - aggl., no 
hemolysis, clear supernatant.
His autocontrol test was negative, but became 
positive with the addition of polyglucin, and there 
was a slight hemolysis of his erythrocytes and serum 
with the addition of complement. The serum of this 
sample did not agglutinate 0 erythrocytes.
Thus, the patient group was defined as A with 
igm anti-b antibodies, weak igG anti-b antibodies, 
weak thermal agglutinating complement-binding 
and hemolytic anti-A igG and thermal autoantibod-
ies (active at 37° c).
Case 3. The patient was assigned O blood 
group, however, her erythrocytes reacted with poly-
clonal anti-b serum at 37° c and anti-b igG. Her 
erythrocytes were not agglutinated with polyclonal 
anti-b serum in the presence of complement and 
anti-b serum after treatment with unithiol in an 
antiglobulin test. in addition, her red blood cells 
reacted with polyclonal anti-A in an antiglobulin 
test, however, anti-A did not agglutinate in the 
presence of complement.
The patient's own serum in the presence of 
complement led to weak agglutination without 
hemolysis. Serum also agglutinated A erythrocytes. 
The serum contained anti-A igG antibodies, because 
after treatment with unithiol it caused hemolysis of 
A erythrocytes in the coombs test, as well as in the 
presence of complement. Serum also agglutinated 
b erythrocytes in a titer of 1: 9, and hemolysis was 
not manifested when complement was introduced.
Possibly, the presence of mixed agglutination 
of her erythrocytes under the influence of anti-b 
polyclonal serum containing traces of A antigen may 
be due to the fixed anti-A antibodies on the patient's 
erythrocytes. The red blood cells of this sample ab-
sorbed anti-b and anti-A antibodies upon absorption. 
This case was defined as the presence of weak A 
and вх antigens, weak anti-A and anti-b antibodies.
© P.G.  Kravchun et al.  Detection of Weak A and b Antigens
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Case 4. The patient was determined blood type 
A (ii). His red blood cells were agglutinated with 
anti-A and anti-A, b sera with hemolysis in the 
presence of complement. His erythrocytes were also 
agglutinated with anti-b serum in the presence of 
complement without hemolysis. At the same time, 
his erythrocytes absorbed anti-A and did not weaken 
the activity of anti-b.
The serum of this patient agglutinated A eryth-
rocytes in the antiglobulin test, but did not lead to 
hemolysis in the presence of complement. After 
treatment with unithiol, his serum also agglutinated 
A erythrocytes in the antiglobulin test, however, ag-
glutination did not appear when rheopolyglucinum 
was introduced into the reaction. So, the presence 
of anti-A igG was determined.
in the presence of complement, his serum ag-
glutinated b erythrocytes without hemolysis. His 
autocontrol test and direct antiglobulin test were 
slightly positive. Thus, the patient was identified as 
a carrier of antigen A with anti-b and weak anti-A 
antibodies.
Case 5. The patient was defined as 0 blood 
group. Her erythrocytes were hemolysed in the 
Table 2
Agglutination and hemolysis of erythrocytes of patients under 
the action of serum of group AB and autoserum




A A+c’ A+AGS b b+c’ b+AGS 0
case 1.  A-ve
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case 4.  A
Autocontrol: S+ DAT: 
S + 
A,  Anti-b,  weak anti-A,  
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case 5.  0
Weak A,b  Hemolysing 
anti-A,b DAT:S+ a/u +P +R +c’:-P














Few er.  +m
a/u













Note: T – transparent; P  – pink; R.  – red; S.  – slightly; rheop: – rheopolyglucinum; AGS – antiglobulin serum; 8.0  – pH 8.0; 
Tur  – turbid; Sev  – severely,  a/u – serum after  unithiol,  c’ – complement,  er.  – erythrocytes; DAT – direct antiglobulin test; 
iAT – indirect antiglobulin test; LiSS – low ionic strength solution; +/- – presence/absence of agglutination; +m – agglutination 
under  microscope.
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Table 3
Agglutination and hemolysis of erythrocytes of the patient’s serum
Note: T – transparent; P  – pink; R.  – red; S.  – slightly; rheop: – rheopolyglucinum; AGS – antiglobulin serum; 8.0  – pH 8.0; 
Tur  – turbid; Sev  – severely,  a/u – serum after  unithiol,  c’ – complement,  er.  – erythrocytes; DAT – direct antiglobulin test; 
iAT – indirect antiglobulin test; LiSS – low ionic strength solution; +/- – presence/absence of agglutination; +m – agglutination 
under  microscope.
 Antigens reacted with the patient’s sample
Serum of the 
patient
A а + с’ а + AGS в  в  + с’ в  + AGS 0  
case 1.  A (ii)  
(Rh-)
Autocontrol:-
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a/u     - - 
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Weak A
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few erycrocytes.,  
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case 9.  
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a/u  - 
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    + с ': - T 








  + P    
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presence of anti-A and anti-A, b serum and comple-
ment. The studied erythrocytes underwent a slight 
hemolysis in the presence of complement; however, 
agglutination was not observed.
The patient absorbed anti-b and anti-A anti-
bodies. Her erythrocytes in the presence of her own 
serum and complement weakly agglutinated with 
manifestations of hemolysis. The direct antiglobulin 
test was slightly positive. The patient's serum agglu-
tinated A and b erythrocytes with hemolysis in the 
presence of complement. So, hemolytically active 
antibodies were present in the serum of this sample.
Case 6. The patient was assigned the group A 
(Rh-) (negative).
His erythrocytes were agglutinated with poly-
clonal anti-A serum and anti-A 2-8 monoclonal 
antibody (mAb) in the presence of complement 
with hemolysis. The sample also reacted with anti-
A, b serum and complement without hemolysis. 
The red blood cells of the patient were slightly 
hemolysed under the influence of anti-A igG and 
complement.
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The patient’s erythrocytes were agglutinated in 
the antiglobulin test with polyclonal anti-A serum 
and anti-A mAb 2-8 (igG3) in the antiglobulin 
test with significant hemolysis. in the presence 
of complement and his own serum treated with 
unithiol, his erythrocytes were slightly hemolysed. 
Patient's serum did not agglutinate 0 erythrocytes.
Thus, the case was defined as a carrier of 
antigen A without the presence of weak antigens.
Case 7. A patient with gonarthrosis and 
periprosthetic infection, developed 2 years after 
surgery, was determined blood group 0 (Rh +) 
(positive). Her erythrocytes did not absorb anti-A 
under normal conditions, only slightly in the pres-
ence of physiological saline with low ionic strength 
(LiSS). From the case history one learnt a positive 
bacteriological growth of Streptococcus hemolyticus 
(sensitive to fluoroquinolones) in the synovial fluid. 
Her red blood cells were weakly agglutinated with 
polyclonal anti-b serum, as well as one of the anti-A 
serums in the presence of complement.
The patient's serum agglutinated A erythro-
cytes, however, agglutinating activity was absent 
after treatment with unithiol. Direct antiglobulin 
test was weakly positive. 
The patient was determined blood type 0 with 
a weak antigen b.
Case 8. The patient was determined blood 
type 0.
She showed the presence of a weak A antigen, 
manifested in the antiglobulin test with polyclonal 
anti-A serum at 37° c, as well as with anti-A igG 
in the presence of complement. Her red blood cells 
were agglutinated with anti-A igG in the presence 
of complement, as well as her own serum in the 
presence of complement. Serum of the sample after 
treatment with unithiol agglutinated b erythrocytes 
in the antiglobulin test. So, the presence of a weak A 
antigen, anti-b and autoantibodies was determined.
Case 9. The patient was determined blood 
type A.
The patient did not show weak antigens, since 
anti-b serum in the presence of complement did 
not contribute to the manifestation of agglutination 
of the studied erythrocytes.
Case 10. blood group 0 was determined for 
the patient. Her erythrocytes absorbed anti-A and 
agglutinated with polyclonal anti-A at 37 ° c, but 
did not agglutinate in the presence of complement 
and in the antiglobulin test. Her serum strongly 
agglutinated A erythrocytes with hemolysis in the 
presence of complement. Direct antiglobulin test 
was negative. The patient was determined to have 
a weak A antigen and hemolytic anti-A and anti-b 
antibodies.
To analyze the nature of the antigen-antibody 
binding observed in these methods and to study 
the state of erythrocytes under the influence of 
polyclonal antibodies, complement and igG, these 
methods were used to detect antigens with the cor-
responding antibodies, i.e. erythrocytes A and anti-A 
and erythrocytes b and anti-b.
So, incubation of polyclonal anti-A serum and 
A erythrocytes with complement led to hemolysis 
and agglutination at 37° c (table 4). The use of 
anti-b and b erythrocytes with complement also 
led to agglutination, and in some cases, the absence 
of hemolysis. Anti-A, b serum in the presence of 
A erythrocytes and complement in most cases also 
led to hemolysis and agglutination, however, in the 
reaction with b erythrocytes, hemolysis in the pres-
ence of agglutination was less common. 
After treatment with unithiol, serum anti-A 
did not agglutinate A erythrocytes, however, the 
use of complement in some cases stimulated ag-
glutination. At the same time, agglutination was 
not observed when anti-b was in contact after 
treatment with unithiol with b erythrocytes and 
complement. 
Anti-A, b after treatment with unithiol led 
Table 4
Agglutination of erythrocytes in the presence of the complement and antibodies
Anti-A + c’ Anti-b + c’ Anti-A,b + c’ Anti-A a/u + c’ Anti-b a/u + c’ Anti-A,b a/u 
+ c’









red (n=1)  + 
(n=3)














+ (n=5)  








- (n=2)  transp  









- transp  (n=1) - (n=2)
+ (n=1)
transp  (n=2)
- (n=1) - transp  (n=1)
Note: c’ – complement,  a/u – after  unithiol,  transp.  – transparent,  +/-  – presence/absence of agglutination.
© P.G.  Kravchun et al.  Detection of Weak A and b Antigens
© Новости хирургии Том 27 * № 5 * 2019
537
to hemolysis of A erythrocytes in the presence of 
complement, while hemolysis with b erythrocytes 
was less common.
A erythrocytes were more prone to hemolysis 
than в erythrocytes in the presence of complement 
and corresponding serum (Fig. 1, 2).
in the reaction of group-specific antibod-
ies and complement, the erythrocyte size were 
slightly smaller in comparison with the reaction 
without complement. However, in the presence of 
hemolysis, erythrocytes became larger in size and 
hypochromia was observed. 
Anti-A serum after treatment with unithiol 
in the presence of complement led to a more 
pronounced destruction of red blood cells and 
their smaller number compared to seras with a 
complete set of igm and igG (Figs. 3, 4). Anti-A, 
b serum after unithiol treatment and interaction 
with complement also led to a decrease in the 
number of red blood cells, their hypochromia, and 
hemolysis compared to sera containing both igm 
and igG (Fig. 5, 6). With 0 erythrocytes, anti-A, 
anti-b and anti-A, b in the presence of comple-
ment in most cases did not lead to agglutination 
and hemolysis.
Discussion
Ab0 subgroups differ in the number of anti-
gens present on red blood cells. Subgroups A are 
more common than subgroups b [4]. Subgroups 
are more often found when there is a discrepancy 
between the direct and reverse methods of typ-
ing groups [5, 6]. The determination of blood 
groups is usually carried out in a direct way and 
rarely the reverse one. As a result, typing may 
become erroneous. The use of molecular, im-
munohistochemical, and genetic methods using 
DNA technologies and genotyping allows one to 
determine the presence of weak subgroups of the 
Ab0 system [7, 8, 9, 10]. Subgroup b, similar to 
subgroup A2, is not described, however, cases 
of determination of erythrocytes in patients that 
have little or no reaction with anti-b sera have 
been reported.
Weak b antigens are proposed to be designated as 
Fig. 1. Anti-A serum and A red blood cells in the 
presence of complement.
Fig. 3. Polyclonal anti-A serum and A red blood cells in 
the presence of complement.
Fig. 2. Anti-B serum and B red blood cells in the 
presence of complement.
Fig. 4. IgG anti-A serum and A red blood cells in the 
presence of complement.
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b3, bx, bm and bel [5]. bx is slightly agglutinated and, 
if present, anti-b antibodies may be present in serum. 
Thus, the presence of a weak b antigen and anti-b 
antibody was determined in one of the patients. in 
this sample (case 5), it was described by some authors 
[11], and we determined in this work the presence 
of weak A and bx antigens hemolyzing anti-A and 
anti-b antibodies. The manifestation of hemolysis of 
the patient’s erythrocytes in the presence of serum 
and complement could be due to the presence of 
autoantibodies. Some authors believe that anti-A, 
anti-b and anti-Ab antibodies reacting at 37° c are 
capable of causing hemolysis in individuals whose 
erythrocytes lack the corresponding antigens [1]
in agglutination reactions, more pronounced 
hemolytic activity with the presence of complement was 
manifested in anti-A serum as compared with anti-b, 
and may be the result of a higher density of A antigens 
on erythrocytes and their stronger absorbing ability [1].
it is rather interesting, that the presence of 
only igG antibodies and complement led to more 
pronounced changes in red blood cells compared 
with the presence of both classes of antibodies.
The presented data are consistent with the 
existing opinion about a stronger complement-
binding and hemolytic ability of igG antibodies [5].
The cases presented illustrate the need for 
additional laboratory methods to detect weak blood 
group antigens.
This work identifies the benefits of using 
the antiglobulin test and agglutination reaction 
in the presence of complement to detect weak A 
and b antigens using the whole serum and serum 
containing only igG antibodies, which can be 
achieved after treatment with unithiol.
Conclusions
1. Typing of blood groups during cross-reaction 
should be carried out both at room temperature and 
Fig. 5. Polyclonal anti-A, B serum and A red blood cells 
in the presence of complement.
Fig. 6. IgG anti-A, B serum and A red blood cells in the 
presence of complement.
at 37° c. An absorption technique and an antiglobulin 
test with donor serum that has undergone and has 
not been treated with unithiol, as well as a reaction 
using complement, can help to identify weak A and 
b antigens on erythrocytes.
2. The presence of weak antibodies to the 
corresponding antigens can be detected at room 
temperature, while igG can be detected at 37° c 
using serum after treatment with unithiol in the 
antiglobulin test. modulation of the activity of these 
antibodies can be studied using rheopolyglukin.
3. The use of complement and group-specific 
antibodies led to a decrease in the size of red 
blood cells with the corresponding Ab0 phenotype. 
increased erythrocyte size and hypochromia have 
been associated with hemolysis.
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